BACKGROUND: In heart failure, brain-type natriuretic peptide (BNP) is elevated and the sarcoplasmic reticulum Ca(2+)-ATPase (SERCA) downregulated. We previously showed that preload-induced SERCA-upregulation is suppressed by exogenous BNP. METHODS AND RESULTS: Here we tested the hypothesis that afterload and neurohumoral activation would counterregulate preload-dependent SERCA upregulation through BNP, which finally results in decreased SERCA levels. We studied the effects of 6 hours preload, afterload, and isoproterenol stimulation on BNP and SERCA mRNA expression in rabbit and human failing muscles strips. Preload resulted in a pronounced upregulation of SERCA by 149% (isotonic versus slack, P<0.01). This upregulation was largely suppressed in afterloaded muscles (isometric versus slack: +32%; P<0.05). Similarly, presence of isoproterenol prevented SERCA upregulation in isotonic muscles. Afterload and isoproterenol resulted in a pronounced increase in BNP expression compared with slack by 225% (P<0.05) and 198% (P<0.01), respectively. Isoproterenol also increased expression of phospholamban by 84% (P<0.01). SERCA upregulation in preloaded muscles is associated with frequency-dependent potentiation of contractile force, which is absent in afterloaded muscles. In failing human myocardium, BNP expression was upregulated compared with nonfailing (+631%; P<0.05). Neither unloading nor preload or afterload induced a change in SERCA or BNP expression after 6 hours. CONCLUSIONS: Afterload and neuroendocrine stimulation increase BNP expression thereby causing inhibition of preload-dependent SERCA upregulation. In failing human myocardium, high BNP expression may underlie the loss of preload-dependent upregulation of SERCA. BNP may thus contribute to adverse myocardial remodelling in heart failure.
BACKGROUND: In heart failure, brain-type natriuretic peptide (BNP) is elevated and the sarcoplasmic reticulum Ca(2+)-ATPase (SERCA) downregulated. We previously showed that preload-induced SERCA-upregulation is suppressed by exogenous BNP. METHODS AND RESULTS: Here we tested the hypothesis that afterload and neurohumoral activation would counterregulate preload-dependent SERCA upregulation through BNP, which finally results in decreased SERCA levels. We studied the effects of 6 hours preload, afterload, and isoproterenol stimulation on BNP and SERCA mRNA expression in rabbit and human failing muscles strips. Preload resulted in a pronounced upregulation of SERCA by 149% (isotonic versus slack, P<0.01). This upregulation was largely suppressed in afterloaded muscles (isometric versus slack: +32%; P<0.05). Similarly, presence of isoproterenol prevented SERCA upregulation in isotonic muscles. Afterload and isoproterenol resulted in a pronounced increase in BNP expression compared with slack by 225% (P<0.05) and 198% (P<0.01), respectively. Isoproterenol also increased expression of phospholamban by 84% (P<0.01). SERCA upregulation in preloaded muscles is associated with frequency-dependent potentiation of contractile force, which is absent in afterloaded muscles. In failing human myocardium, BNP expression was upregulated compared with nonfailing (+631%; P<0.05). Neither unloading nor preload or afterload induced a change in SERCA or BNP expression after 6 hours. CONCLUSIONS: Afterload and neuroendocrine stimulation increase BNP expression thereby causing inhibition of preload-dependent SERCA upregulation. In failing human myocardium, high BNP expression may underlie the loss of preload-dependent upregulation of SERCA. BNP may thus contribute to adverse myocardial remodelling in heart failure.
Authors: Karl Toischer; Adam G Rokita; Bernhard Unsöld; Wuqiang Zhu; Georgios Kararigas; Samuel Sossalla; Sean P Reuter; Alexander Becker; Nils Teucher; Tim Seidler; Cornelia Grebe; Lena Preuss; Shamindra N Gupta; Kathie Schmidt; Stephan E Lehnart; Martina Krüger; Wolfgang A Linke; Johannes Backs; Vera Regitz-Zagrosek; Katrin Schäfer; Loren J Field; Lars S Maier; Gerd Hasenfuss Journal: Circulation Date: 2010-08-23 Impact factor: 29.690
Authors: Constance G Weismann; Joanna Hlebowicz; Anna Åkesson; Petru Liuba; Katarina Hanseus Journal: Front Physiol Date: 2022-04-25 Impact factor: 4.755
Authors: Belal A Mohamed; Abdul R Asif; Moritz Schnelle; Mohamed Qasim; Sara Khadjeh; Dawid Lbik; Peter Schott; Gerd Hasenfuss; Karl Toischer Journal: J Transl Med Date: 2016-05-27 Impact factor: 5.531
Authors: Lydia Coulter Kwee; Megan L Neely; Elizabeth Grass; Simon G Gregory; Matthew T Roe; E Magnus Ohman; Keith A A Fox; Harvey D White; Paul W Armstrong; Lenden M Bowsman; Joseph V Haas; Kevin L Duffin; Mark Y Chan; Svati H Shah Journal: Physiol Genomics Date: 2019-09-18 Impact factor: 3.107
Authors: Hanna Schotola; Samuel T Sossalla; André Renner; Jan Gummert; Bernhard C Danner; Peter Schott; Karl Toischer Journal: ESC Heart Fail Date: 2017-04-19